Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemia

Atherogenic mixed dyslipidemia associates with oxidative stress and defective HDL antioxidative function in metabolic syndrome (MetS). The impact of statin treatment on the capacity of HDL to inactivate LDL-derived, redox-active phospholipid hydroperoxides (PCOOHs) in MetS is indeterminate. Insulin-...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Lipid Res
Asıl Yazarlar: Orsoni, Alexina, Thérond, Patrice, Tan, Ricardo, Giral, Philippe, Robillard, Paul, Kontush, Anatol, Meikle, Peter J., Chapman, M. John
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The American Society for Biochemistry and Molecular Biology 2016
Konular:
Patient-Oriented and Epidemiological Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5087874/
https://ncbi.nlm.nih.gov/pubmed/27581680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.P068585
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller